Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

STOK holding history

Stoke Therapeutics, Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

STOK overviewAll 13F holders of STOKFull Q2 2026 holdings

Shares (Q2 2026)
178,110
Value
$5.83M
% of portfolio
2.7%
Quarters held
22
Since Q1 2021
Holdings of STOK by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026178,110$5.83M2.7%−31,890−15.2%ReducedHolders
Q1 2026210,000$6.84M3.9%−50,000−19.2%ReducedHolders
Q4 2025260,000$8.25M4.8%+50,000+23.8%AddedHolders
Q3 2025210,000$4.93M3.7%00.0%UnchangedHolders
Q2 2025210,000$2.38M2.4%−50.0%ReducedHolders
Q1 2025210,005$1.40M1.2%+50.0%AddedHolders
Q4 2024210,000$2.32M1.9%00.0%UnchangedHolders
Q3 2024210,000$2.58M2.2%00.0%UnchangedHolders
Q2 2024210,000$2.84M2.6%00.0%UnchangedHolders
Q1 2024210,000$2.83M2.3%00.0%UnchangedHolders
Q4 2023210,000$1.10M0.9%+125,000+147.1%AddedHolders
Q3 202385,000$334.9K0.3%00.0%UnchangedHolders
Q2 202385,000$903.5K0.7%+70,000+466.7%AddedHolders
Q1 202315,000$125.0K0.1%00.0%UnchangedHolders
Q4 202215,000$138.0K0.1%00.0%UnchangedHolders
Q3 202215,000$193.0K0.1%00.0%UnchangedHolders
Q2 202215,000$198.0K0.1%00.0%UnchangedHolders
Q1 202215,000$316.0K0.2%00.0%UnchangedHolders
Q4 202115,000$360.0K0.2%00.0%UnchangedHolders
Q3 202115,000$382.0K0.3%00.0%UnchangedHolders
Q2 202115,000$505.0K0.3%00.0%UnchangedHolders
Q1 202115,000$583.0K0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.